Announcement of an Exempt Purchase

INOmax (nitric oxide) therapeutic respiratory delivery systems required for the treatment of newborns with hypoxic respiratory failure.

This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical services necessary for the delivery of care and treatment at medical, dental, or veterinary teaching facilities utilized by SIU or U of I (30 ILCS 500 / 1-13(b-5)) The nitric oxide is needed for the therapeutic respiratory delivery systems. The FDA approved systems are used to treat newborns with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension. The therapeutic delivery systems consist of the following: mechanical ventilator, cylinder, calibration gases, injector modules, flowmeter kit, and tubing for the delivery of nitric oxide in purified form.